Works matching IS 02704137 AND DT 2003 AND VI 56 AND IP 1

Results: 9

Luteinizing hormone β polymorphism and risk of familial and sporadic prostate cancer (David A. Elkins and Akira Yokomizo contributed equally to this work.).

Published in:

Prostate, 2003, v. 56, n. 1, p. 30, doi. 10.1002/pros.10220

By:

David A. Elkins;
Akira Yokomizo;
Stephen N. Thibodeau;
Daniel J. Schaid;
Julie M. Cunningham;
Angela Marks;
Eric Christensen;
Shannon K. McDonnell;
Susan Slager;
Brett J. Peterson;
Steven J. Jacobsen;
James R. Cerhan;
Michael L. Blute;
Donald J. Tindall;
Wanguo Liu

Publication type:

Article

Prostate cancer expression of runt-domain transcription factor Runx2, a key regulator of osteoblast differentiation and function.

Published in:

Prostate, 2003, v. 56, n. 1, p. 13, doi. 10.1002/pros.10233

By:

Kristen D. Brubaker;
Robert L. Vessella;
Lisha G. Brown;
Eva Corey

Publication type:

Article

Anti-androgenic action by red clover-derived dietary isoflavones reduces non-malignant prostate enlargement in aromatase knockout (arko) mice.

Published in:

Prostate, 2003, v. 56, n. 1, p. 54, doi. 10.1002/pros.10230

By:

Renea A. Jarred;
Stephen J. McPherson;
Margaret E.E. Jones;
Evan R. Simpson;
Gail P. Risbridger

Publication type:

Article

Evaluation of SRD5A2 sequence variants in susceptibility to hereditary and sporadic prostate cancer.

Published in:

Prostate, 2003, v. 56, n. 1, p. 37, doi. 10.1002/pros.10225

By:

Bao-li Chang;
S. Lilly Zheng;
Sarah D. Isaacs;
Aubrey R. Turner;
Eugene R. Bleecker;
Patrick C. Walsh;
Deborah A. Meyers;
William B. Isaacs;
Jianfeng Xu

Publication type:

Article

Development of a quantitative RT-PCR method to study 5α-reductase mRNA isozymes in rat prostate in different androgen status.

Published in:

Prostate, 2003, v. 56, n. 1, p. 74, doi. 10.1002/pros.10221

By:

Jesus M. Torres;
Estrella Ruiz

Publication type:

Article

Prediction of extraprostatic cancer by prostate specific antigen density, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer.

Published in:

Prostate, 2003, v. 56, n. 1, p. 23, doi. 10.1002/pros.10239

By:

Akio Horiguchi;
Jun Nakashima;
Yutaka Horiguchi;
Ken Nakagawa;
Mototsugu Oya;
Takashi Ohigashi;
Ken Marumo;
Masaru Murai

Publication type:

Article

Disabled infectious single cycle herpes simplex virus (DISC-HSV) is a candidate vector system for gene delivery/expression of GM-CSF in human prostate cancer therapy (Richard J. Parkinson and Shahid Mian have contributed equally to the study.).

Published in:

Prostate, 2003, v. 56, n. 1, p. 65, doi. 10.1002/pros.10207

By:

Richard J. Parkinson;
Shahid Mian;
Michael C. Bishop;
Trevor Gray;
Geng Li;
Stephanie E.B. McArdle;
Selman Ali;
Robert C. Rees

Publication type:

Article

Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: Implication of epidermal growth factor receptor down-regulation and ceramide production.

Published in:

Prostate, 2003, v. 56, n. 1, p. 1, doi. 10.1002/pros.10190

By:

Murielle Mimeault;
Nicole Pommery;
Nicole Wattez;
Christian Bailly;
Jean-Pierre Hénichart

Publication type:

Article

Prostate-specific antigen (PSA) protein does not affect growth of prostate cancer cells in vitro or prostate cancer xenografts in vivo.

Published in:

Prostate, 2003, v. 56, n. 1, p. 45, doi. 10.1002/pros.10213

By:

Samuel R. Denmeade;
Ivan Litvinov;
Lori J. Sokoll;
Hans Lilja;
John T. Isaacs

Publication type:

Article